Published in Blood on December 13, 2005
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
Response to mercaptopurine for refractory autoimmune cytopenias in children. Pediatr Blood Cancer (2009) 1.49
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood (2012) 1.28
Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis. Arthritis Res Ther (2009) 1.26
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer (2009) 1.09
Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States. J Pediatr (2012) 0.92
Repeated courses of rituximab in chronic ITP: Three different regimens. Am J Hematol (2009) 0.92
Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration. Haematologica (2014) 0.90
Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report. Br J Haematol (2013) 0.89
Rituximab for children with immune thrombocytopenia: a systematic review. PLoS One (2012) 0.89
Biologics in children's autoimmune disorders: efficacy and safety. Eur J Pediatr (2010) 0.88
Clinical practice: immune thrombocytopenia in paediatrics. Eur J Pediatr (2014) 0.88
Treatment with rituximab in benign and malignant hematologic disorders in children. J Pediatr (2007) 0.84
Romiplostim as a treatment for immune thrombocytopenia: a review. J Blood Med (2015) 0.82
B cell depletion for autoimmune diseases in paediatric patients. Clin Rheumatol (2010) 0.81
Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences. Biologics (2008) 0.80
Health-related quality of life in children with newly diagnosed immune thrombocytopenia. Haematologica (2014) 0.80
Rituximab therapy for chronic and refractory immune thrombocytopenic purpura: a long-term follow-up analysis. Ann Hematol (2007) 0.80
Rituximab therapy for refractory autoimmune thrombocytopenia in patients with systemic lupus erythematosus. Turk J Haematol (2012) 0.79
Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia. Pediatr Blood Cancer (2011) 0.78
Antibody therapy of pediatric B-cell lymphoma. Front Oncol (2013) 0.75
Childhood immune thrombocytopenia: Clinical presentation and management. Sudan J Paediatr (2012) 0.75
Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults? Cancers (Basel) (2015) 0.75
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol (1998) 8.40
IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood (1997) 4.97
Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr (2005) 2.97
Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura. Blood (2001) 2.59
Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood (1994) 2.48
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr (2003) 2.24
B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Haematologica (2002) 1.72
The spectrum of Evans' syndrome. Arch Dis Child (1997) 1.69
Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr (2002) 1.58
The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. Br J Haematol (2004) 1.43
A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia. Semin Oncol (2000) 1.11
Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study. Eur J Haematol (2002) 1.00
[Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)]. Arch Pediatr (2005) 0.99
Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood (2002) 0.94
Effect of a single dose of rituximab in chronic immune thrombocytopenic purpura in childhood. Haematologica (2005) 0.90
Successful use of anti-CD20 (rituximab) in severe, life-threatening childhood immune thrombocytopenic purpura. J Pediatr (2003) 0.85
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89
International consensus report on the investigation and management of primary immune thrombocytopenia. Blood (2009) 7.72
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet (2011) 7.30
A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med (2012) 6.86
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med (2007) 6.76
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell (2002) 6.64
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37
JAK mutations in high-risk childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2009) 4.98
Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med (2004) 4.95
Inhibitors of factor VIII in black patients with hemophilia. N Engl J Med (2009) 4.82
Effects of decreasing sugar-sweetened beverage consumption on body weight in adolescents: a randomized, controlled pilot study. Pediatrics (2006) 4.70
Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58
Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA (2012) 4.33
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study. Lancet (2010) 4.20
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell (2008) 4.06
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (2008) 3.74
B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol (2011) 3.66
Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med (2008) 3.44
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2011) 3.40
Improved survival of children and adolescents with sickle cell disease. Blood (2010) 3.30
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res (2004) 3.20
Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet (2003) 3.07
Complications of beta-thalassemia major in North America. Blood (2004) 2.97
Chronic immune thrombocytopenic purpura in children: assessment of rituximab treatment. J Pediatr (2005) 2.97
Survival of children with sickle cell disease. Blood (2004) 2.84
The ITP syndrome: pathogenic and clinical diversity. Blood (2009) 2.83
Thyroid hormone inactivation in gastrointestinal stromal tumors. N Engl J Med (2014) 2.80
Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up. Arch Pediatr Adolesc Med (2010) 2.68
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol (2014) 2.67
Effects of a low-glycemic load vs low-fat diet in obese young adults: a randomized trial. JAMA (2007) 2.66
Compensation for energy intake from fast food among overweight and lean adolescents. JAMA (2004) 2.57
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol (2010) 2.55
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer (2010) 2.36
Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics (2006) 2.35
Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood (2013) 2.27
A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr (2003) 2.24
Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents. Blood (2010) 2.21
High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci Transl Med (2012) 2.20
Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura. Blood (2008) 2.17
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol (2007) 2.14
Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood (2008) 2.13
Rachitic changes, demineralization, and fracture risk in healthy infants and toddlers with vitamin D deficiency. Radiology (2011) 2.10
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood (2010) 2.09
Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2012) 2.09
How I treat idiopathic thrombocytopenic purpura (ITP). Blood (2005) 2.05
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia. Nat Genet (2010) 2.03
Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr (2005) 2.03
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk. Blood (2008) 2.03
Invasive pneumococcal infections in children with sickle cell disease in the era of penicillin prophylaxis, antibiotic resistance, and 23-valent pneumococcal polysaccharide vaccination. J Pediatr (2003) 2.00
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood (2005) 1.99
Antenatal hydronephrosis as a predictor of postnatal outcome: a meta-analysis. Pediatrics (2006) 1.98
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood (2005) 1.96
Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood (2009) 1.96
Children and adolescents with gender identity disorder referred to a pediatric medical center. Pediatrics (2012) 1.95
The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell (2005) 1.90
Stroke With Transfusions Changing to Hydroxyurea (SWiTCH): a phase III randomized clinical trial for treatment of children with sickle cell anemia, stroke, and iron overload. Pediatr Blood Cancer (2011) 1.89
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia. Blood (2011) 1.89
Vascular complications after splenectomy for hematologic disorders. Blood (2009) 1.89
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study. Blood (2012) 1.88
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia. Blood (2011) 1.85
Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med (2014) 1.81
Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? Blood (2003) 1.81
Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst (2013) 1.81
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease. Blood (2005) 1.80
School-based health education programs can be maintained over time: results from the CATCH Institutionalization study. Prev Med (2004) 1.80
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population. Blood (2011) 1.80
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood (2012) 1.78
Cytomegalovirus can make immune thrombocytopenic purpura refractory. Br J Haematol (2009) 1.78
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease. Neurology (2013) 1.78
Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res (2008) 1.77
A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease. Br J Haematol (2007) 1.77
Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. J Pediatr (2007) 1.75
Transcranial doppler ultrasonography (TCD) in infants with sickle cell anemia: baseline data from the BABY HUG trial. Pediatr Blood Cancer (2010) 1.75
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood (2013) 1.73
Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP). Am J Hematol (2003) 1.70
Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res (2013) 1.68
Relation of body fat indexes to vitamin D status and deficiency among obese adolescents. Am J Clin Nutr (2009) 1.66
Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia. Blood (2012) 1.66
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol (2013) 1.66
Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura. Blood (2008) 1.63
Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer (2008) 1.62
CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J Exp Med (2007) 1.61
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol (2009) 1.59
Hemoglobin Jamaica plain--a sickling hemoglobin with reduced oxygen affinity. N Engl J Med (2004) 1.59
Urinary hepcidin in congenital chronic anemias. Pediatr Blood Cancer (2007) 1.58
Neurodevelopmental outcome in survivors of periventricular hemorrhagic infarction. Pediatrics (2007) 1.55
Inherited predispositions and hyperactive Ras in myeloid leukemogenesis. Pediatr Blood Cancer (2006) 1.54